News Search Results
Jun 17, 2025, 08:00 ET NSCEB Selection of North Carolina as First Stop on National Tour Highlights Impact of Collaboration in Biotech Industry
National Security Commission on Emerging Biotechnology (NSCEB) during the first stop on its nationwide biotechnology roadshow. The visit marked a historic moment not only for Novonesis but for North Carolina's
More news about: Novonesis
Jun 17, 2025, 08:00 ET Catalyst Clinical Research Named to Inc.'s 2025 Best Workplaces List
Catalyst Clinical Research, a contract research organization (CRO) providing highly customizable solutions to the global biopharmaceutical and biotechnology industries, has once again been named to
More news about: Catalyst Clinical Research
Jun 17, 2025, 07:30 ET Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver 9 Phase 2 Readouts
June 17, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory
More news about: Spyre Therapeutics, Inc.
Jun 17, 2025, 06:53 ET European Direct-to-Consumer Genetic Testing Market to Reach USD 3.78 Billion by 2035, Says Meticulous Research®
The European direct-to-consumer genetic testing market features a diverse competitive landscape with established genetic testing companies, biotechnology specialists, digital health solution providers, and innovative genomics startups pursuing varied approaches to consumer genetic testing implementation.
More news about: Meticulous Market Research Pvt. Ltd.
Jun 17, 2025, 06:45 ET Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jun 17, 2025, 06:00 ET HanchorBio Presents Promising Data on HCB101 Checkpoint Inhibitor Immunotherapy at ASCO
Shanghai, and the San Francisco Bay Area, HanchorBio is a global clinical-stage biotechnology company focusing on immuno-oncology. Led by an experienced team of pharmaceutical industry veterans, the company is focused on reactivating the
More news about: HanchorBio Inc.
Jun 17, 2025, 05:00 ET Exobiosphere and Space Cargo Unlimited Unite for High-Throughput Biotech in Space
announced the signing of a Memorandum of Understanding (MoU) during the Paris Air Show to launch joint space missions focused on high-throughput biotechnology research. High-throughput screening (HTS) is a drug discovery process that allows for the rapid testing of thousands of chemical compounds to identify
More news about: Space Cargo Unlimited; Exobiosphere
Jun 17, 2025, 05:00 ET Exobiosphere and Space Cargo Unlimited Unite for High-Throughput Biotech in Space
announced the signing of a Memorandum of Understanding (MoU) during the Paris Air Show to launch joint space missions focused on high-throughput biotechnology research. High-throughput screening (HTS) is a drug discovery process that allows for the rapid testing of thousands of chemical compounds to identify
More news about: Space Cargo Unlimited; Exobiosphere
Jun 17, 2025, 00:48 ET Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today announced that enrollment
More news about: Clover Biopharma
Jun 16, 2025, 19:48 ET U.S. Food and Drug Administration Approves CSL's ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All Patients From the Start
KING OF PRUSSIA, Pa., June 16, 2025 /PRNewswire/ -- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced the U.S. Food and Drug Administration (FDA) approved ANDEMBRY® (garadacimab-gxii),
More news about: CSL
Jun 16, 2025, 18:42 ET Pressure Switches Market Size to Reach $2.03 Billion by 2031, Experiences by Growth Owing to Rising Adoption of Smart Factories and Industrial Automation
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 16, 2025, 16:05 ET Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trials for its SPY002 Program, its Novel Half-Life Extended Anti-TL1A Antibodies on June 17, 2025
June 16, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of Inflammatory
More news about: Spyre Therapeutics, Inc.
Jun 16, 2025, 14:26 ET C-Path's New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects
management. IHI is a partnership between the European Union and European industry associations representing the pharmaceutical, medical technology, biotechnology, digital health and vaccine industries, namely COCIR, EFPIA, EuropaBio, MedTech Europe and Vaccines Europe. IHI's total budget is EUR
More news about: Critical Path Institute
Jun 16, 2025, 13:57 ET C-Path's New Paper in Nature Reviews Drug Discovery Highlights How to Maximize the Regulatory Impact of Consortium-Based Projects
management. IHI is a partnership between the European Union and European industry associations representing the pharmaceutical, medical technology, biotechnology, digital health and vaccine industries, namely COCIR, EFPIA, EuropaBio, MedTech Europe and Vaccines Europe. IHI's total budget is EUR
More news about: Critical Path Institute
Jun 16, 2025, 12:01 ET Perfusion Medical Announces Scholarship from Virginia Bio to Participate in 2025 BIO International Convention
life-saving, acute cardiovascular therapies to transform intensive care medicine, today announced that it has received a scholarship from the Virginia Biotechnology Research Partnership Authority to participate in the BIO International Convention, June 16-19, 2025, in Boston,
More news about: Perfusion Medical
Jun 16, 2025, 11:58 ET Land Mobile Radio Market Size to Reach $24.32 Billion by 2031, Growing at a 10.9% CAGR
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 16, 2025, 11:46 ET Live IP Broadcast Equipment Market Size to Grow USD 5.66 Billion by 2031 | 17.6% CAGR
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jun 16, 2025, 11:25 ET Microbial Food Ingredient Market to Hit USD 4.29 Billion by 2031, Driven by Clean Label and Probiotic Demand ' | Valuates Reports'
trends, functional food innovation, and rising global interest in gut microbiome science. Manufacturers are leveraging fermentation and microbial biotechnology to enhance product quality, nutrition, and safety. From dairy and drinks to plant-based and nutraceutical sectors, microbial ingredients offer versatile
More news about: Valuates Reports
Jun 16, 2025, 10:05 ET Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies
of other cancer therapeutics such as radiopharmaceutical therapy." About ShasqiShasqi, Inc. is a preclinical biotechnology company whose focus is to make cancer drugs more effective with pre-targeting enabled by click chemistry, a 2022 Nobel Prize winning innovation.
More news about: Shasqi, Inc.
Jun 16, 2025, 08:20 ET Cresilon Announces International Distribution Agreement for VETIGEL with McCarthy Vet
June 16, 2025 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into a distribution agreement for VETIGEL® to be sold
More news about: Cresilon
Jun 16, 2025, 08:08 ET "Luminous Path, Shared Stride - Brazil and China"
https://www.prnewswire.com/news-releases/luminous-path-shared-stride--brazil-and-china-302482141.html SOURCE SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD
Jun 16, 2025, 08:00 ET Precisio Biotix Therapeutics, Inc. (Precisio) Announces a Grant for the Discovery of Novel Engineered Lysin Antimicrobials Targeting Bacterial Vaginosis Associated Pathobionts (BV)
engineered lysins with potent activity against the major bacterial pathogens causing bacterial vaginosis (BV). Precisio is an American biotechnology company developing pathogen-specific lysin biotherapeutics and antibacterials using computational protein designs and related high-tech platforms.
More news about: Precisio Biotix Therapeutics, Inc.
Jun 16, 2025, 08:00 ET Hoth Therapeutics to Attend 2025 BIO International Convention
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. To learn more about this event visit
More news about: Hoth Therapeutics, Inc.
Jun 16, 2025, 07:15 ET ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
B-cell malignancies and earlier lines of therapy. About ADC Therapeutics ADC Therapeutics (NYSE: ADCT) is a commercial-stage biotechnology company helping to improve the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates (ADCs). The Company
More news about: ADC Therapeutics SA
Jun 16, 2025, 07:00 ET Solu Therapeutics Appoints Enda Moran, PhD, MBA as Chief Operating Officer
BOSTON, June 16, 2025 /PRNewswire/ -- Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the appointment
More news about: Solu Therapeutics